Back to Search Start Over

Can Component Size in Total Knee Arthroplasty Be Predicted Preoperatively?-An Analysis of Patient Characteristics.

Authors :
Naylor BH
Butler JT
Kuczynski B
Bohm AR
Scuderi GR
Source :
The journal of knee surgery [J Knee Surg] 2023 Jul; Vol. 36 (9), pp. 965-970. Date of Electronic Publication: 2022 Jul 12.
Publication Year :
2023

Abstract

Accurately predicting component sizing in total knee arthroplasty (TKA) can ensure appropriate implants are readily available, avoiding complications from malsizing while also reducing cost by improving workflow efficiency through a reduction in instrumentation. This study investigated the utility of demographic variables to reliably predict TKA component sizes. A retrospective chart review of 337 patients undergoing primary TKA was performed. Patient characteristics (age, sex, race, height, weight) were recorded along with implant and shoe size. Correlation between shoe size and TKA component size was assessed using Pearson's correlation coefficient and linear regression analysis using three models: (A) standard demographic variables, (B) shoe size, and (C) combination of both models. Shoe size demonstrated the strongest correlation with femoral anteroposterior (FAP) ( p  < 0.001) followed by height ( p  < 0.001). Conversely, height exhibited the strongest correlation with tibial mediolateral (TML) ( p  < 0.001) followed by shoe size ( p  < 0.001). Model C was able to correctly predict both the femur and tibia within one and two sizes in 83.09 and 98.14% of cases, respectively. Individually, model C predicted the FAP within one and two sizes in 83.09 and 96.14% of cases, and the TML in 98.81 and 100% of cases, respectively. A patient's shoe size demonstrates a strong correlation to the TKA implant size, and when combined with standard demographic variables the predictive reliability is further increased. Here, we present a predictive model for implant sizing based solely on easily attainable demographic variables, that will be useful for preoperative planning to improve surgical efficiency. LEVEL OF EVIDENCE:  II, Diagnostic.<br />Competing Interests: G.R.S. receives royalties from Zimmer Biomet. personal fees from Zimmer Biomet, 3M KCL, ROM Tech, and FORCE therapeutics, outside the submitted work. The rest authors declare no conflict of interest.<br /> (Thieme. All rights reserved.)

Details

Language :
English
ISSN :
1938-2480
Volume :
36
Issue :
9
Database :
MEDLINE
Journal :
The journal of knee surgery
Publication Type :
Academic Journal
Accession number :
35820432
Full Text :
https://doi.org/10.1055/s-0042-1748902